Top 100 in Cancer – 2022
Nature Scientific Reports
This collection highlights our most downloaded cancer papers published in 2022. Featuring authors from around the world, these papers showcase valuable research from an international community.
Cofactor Genomics Opens Enrollment for Non-small Cell Lung Cancer Study of OncoPrism Predictive Diagnostic Assay
Business Wire
SAN FRANCISCO–(BUSINESS WIRE)–Cofactor Genomics, the diagnostics company bridging the precision medicine gap, today announced commencement of a study of its OncoPrism™ assay in [...]
Predictive diagnostics: closing the precision medicine gap
Drug Discovery World
Jarret Glasscock, PhD, CEO of Cofactor Genomics explains how diagnostics are emerging as the key to ensuring the right patients get matched to the right therapy, at the right time. Precision [...]
Cofactor Genomics Unveils New Data Showing Novel OncoPrism Diagnostic is Nearly Twice as Accurate as PD-L1 in Identifying Immunotherapy Responders
Cofactor Genomics
Readout from the national PREDAPT multicenter clinical trial presented at AGBT Precision Health Conference Cofactor Genomics, a Predictive Immune Modeling company, today presented initial results [...]
T Cell State of Mind
The Pathologist
Comprehensive immune profiling may lead to better prediction of immunotherapy response What must we do to improve outcomes for cancer patients? The answer is simple – gain a better understanding [...]
Mind the Gap: Recognizing and Closing the Precision Medicine Gap
Clp Mag
A familiar refrain for those who have traveled on London’s tube, “mind the gap” is a warning to take caution while crossing between the station platform and the train door. In oncology, patients [...]
Expanding RNA-Based Immune Profiling to Immune State Makes Precision Medicine More Precise
Cell and gene
The race to cure cancer has focused on drug discovery; in the last five years, clinical trials increased 500% for new drugs. Genome targeted therapies were an early source of excitement, but only [...]
Cofactor Genomics Publishes Superiority of T Cell State Profiling in Predicting Patient’s Response to Immunotherapy
Cofactor Genomics
SAN FRANCISCO – February 15, 2022 – Cofactor Genomics today announced publication in the latest issue of Nature Scientific Reports of a study showing that the company’s multianalyte [...]
Cofactor Genomics Commences First Predictive Immune Modeling Clinical Trial to Bridge Precision Medicine Gap for Immunotherapy
Cofactor Genomics
SAN FRANCISCO, Calif. – April 13, 2021 – Cofactor Genomics, the company bridging the precision medicine gap, today announced commencement of the first multicenter clinical trial of its [...]
New Data Published from Women & Infants Hospital Demonstrate Utility of Predictive Immune Modeling in Ovarian Cancer
Cofactor Genomics
PROVIDENCE, R.I. – March 8, 2021 (Reportable News)– Cofactor Genomics, the company bridging the precision medicine gap, announced today new data published in Frontiers in Oncology by Women & [...]
